PT1265904E - Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento - Google Patents

Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento

Info

Publication number
PT1265904E
PT1265904E PT01911553T PT01911553T PT1265904E PT 1265904 E PT1265904 E PT 1265904E PT 01911553 T PT01911553 T PT 01911553T PT 01911553 T PT01911553 T PT 01911553T PT 1265904 E PT1265904 E PT 1265904E
Authority
PT
Portugal
Prior art keywords
preparation
treatment
pharmaceutically acceptable
acceptable carrier
relates
Prior art date
Application number
PT01911553T
Other languages
English (en)
Inventor
Thomas Weiser
Karin Winter
Stefan Matthias Blech
Angelo Ceci
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT1265904E publication Critical patent/PT1265904E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT01911553T 2000-02-02 2001-01-30 Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento PT1265904E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10004572A DE10004572A1 (de) 2000-02-02 2000-02-02 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PT1265904E true PT1265904E (pt) 2004-11-30

Family

ID=7629599

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01911553T PT1265904E (pt) 2000-02-02 2001-01-30 Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento

Country Status (16)

Country Link
US (3) US6525045B2 (pt)
EP (1) EP1265904B1 (pt)
JP (1) JP4891510B2 (pt)
AR (1) AR027352A1 (pt)
AT (1) ATE277054T1 (pt)
AU (1) AU2001240561A1 (pt)
CA (1) CA2399377C (pt)
CO (1) CO5261505A1 (pt)
DE (2) DE10004572A1 (pt)
DK (1) DK1265904T3 (pt)
ES (1) ES2228817T3 (pt)
MX (1) MXPA02007460A (pt)
PT (1) PT1265904E (pt)
TR (1) TR200402650T4 (pt)
UY (1) UY26566A1 (pt)
WO (1) WO2001057045A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
KR20020082896A (ko) * 2000-03-21 2002-10-31 스미스클라인 비참 코포레이션 프로테아제 억제제
EP2311440A1 (en) * 2001-04-05 2011-04-20 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
DE10123952A1 (de) * 2001-05-17 2002-11-21 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20030100552A1 (en) 2001-05-17 2003-05-29 Boehringer Ingelheim Pharma Kg Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions
JP2005508352A (ja) 2001-10-10 2005-03-31 ニューロサーチ、アクティーゼルスカブ 新規ベンゾチアジン誘導体、その製造方法及びその使用方法
US7815391B2 (en) * 2004-07-23 2010-10-19 Kauppila Richard W Structural member joints
WO2006034196A1 (en) * 2004-09-17 2006-03-30 Lifelike Biomatic Inc. Compositions for enhancing memory and methods therefor
EP2280942A1 (en) 2008-05-05 2011-02-09 Lonza Ltd. Indolesulfonyl protecting groups for protection of guanidino and amino groups
WO2010054336A2 (en) * 2008-11-10 2010-05-14 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
EP3008167A4 (en) 2013-06-13 2017-06-07 VeroScience LLC Compositions and methods for treating metabolic disorders
EP3436021A4 (en) 2016-03-29 2019-11-06 RespireRx Pharmaceuticals Inc. COMPOSITIONS AND METHODS FOR TREATING ATTENTION DEFICIT DISORDER

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
US4994452A (en) * 1989-11-28 1991-02-19 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
EP0636124A1 (fr) * 1992-04-15 1995-02-01 Aventis Pharma S.A. Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant
DK0760819T3 (da) * 1994-05-24 2000-10-09 Hoffmann La Roche Tricykliske dicarbonylderivater
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
US5968928A (en) * 1996-09-19 1999-10-19 Warner-Lambert Company Excitatory amino acid antagonists: fused-azacyclic quinoxalinediones and immunoassays thereof
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response
IL137720A0 (en) * 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
US6096744A (en) * 1998-05-04 2000-08-01 Warner-Lambert Company Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
US20020013313A1 (en) 2002-01-31
UY26566A1 (es) 2001-08-27
ES2228817T3 (es) 2005-04-16
US6525045B2 (en) 2003-02-25
US20030158181A1 (en) 2003-08-21
JP4891510B2 (ja) 2012-03-07
CA2399377C (en) 2008-12-16
MXPA02007460A (es) 2003-01-28
CO5261505A1 (es) 2003-03-31
JP2003522180A (ja) 2003-07-22
EP1265904B1 (de) 2004-09-22
WO2001057045A1 (de) 2001-08-09
CA2399377A1 (en) 2001-08-09
US20030158183A1 (en) 2003-08-21
EP1265904A1 (de) 2002-12-18
DE50103760D1 (de) 2004-10-28
DK1265904T3 (da) 2004-10-25
AU2001240561A1 (en) 2001-08-14
TR200402650T4 (tr) 2004-11-22
AR027352A1 (es) 2003-03-26
ATE277054T1 (de) 2004-10-15
US6800623B2 (en) 2004-10-05
DE10004572A1 (de) 2001-08-09

Similar Documents

Publication Publication Date Title
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
NO20001870D0 (no) Ny fremgangsmõte for behandling
DE59900101D1 (de) Medizinisches Instrument zum Präparieren von Gewebe
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
FI20012426L (fi) Komposiitti-nonwoven, sen käyttö ja menetelmä sen valmistamiseksi
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
HUP0300209A3 (en) Lipid nanocapsules, preparation method and use as medicine
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
MXPA02011474A (es) Toalla para lavado desechable y metodo de uso.
FIU20060389U0 (fi) Luusairauksien hoito
AU7345400A (en) A method of treatment of human immunodeficiency diseases
PT1265904E (pt) Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento
AU1167602A (en) Methods of therapy for hiv infection
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
DE60032884D1 (de) Blutbehandlungssystem
AU2000258352A1 (en) Acupuncture points stimulation for treating various diseases
HUP0300700A3 (en) Method for permanently shaping keratin fibres, and agents
NO20013337L (no) Ny behandling
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
AU2002220257A1 (en) Methods of treatment involving human mda-7
IL154358A0 (en) Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
LV12656B (lv) Arstniecibas lidzeklis un panemiens opija narkomanijas pacientu arstesanai